You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nuclear

Showing 1 - 25 of 4,418
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nuclear Cataract Trial in Rotterdam (Lens fragmentation)

Not yet recruiting
  • Nuclear Cataract
  • Lens fragmentation
  • Rotterdam, Netherlands
    Oogziekenhuis Rotterdam
Feb 9, 2023

Cancer, Myocarditis, Alzheimer Trial in Vandoeuvre les Nancy (Ericksonian Hypnosis, Hypnosis)

Recruiting
  • Cancer
  • +3 more
  • Ericksonian Hypnosis
  • Hypnosis
  • Vandoeuvre les Nancy, France
    Nancy Hospital
Oct 30, 2023

NUclear MEdicine DIagnostic and Artificial Intelligence

Not yet recruiting
  • Hyperparathyroidism
  • treatment program
  • (no location specified)
Jul 25, 2023

Nuclear Magnetic Resonance for Embryo Ploidy Selection

Recruiting
  • Aneuploidy
  • Infertility
  • Nuclear magnetic resonance analysis of embryo culture medium
  • Lisbon, Portugal
    Instituto Valenciano de Infertilidade
Aug 2, 2022

Gynecologic Cancer, Cervical Cancer, Endometrial Cancer Trial in Taoyuan City (Hyperpolarized 13C-Pyruvate injection)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Hyperpolarized 13C-Pyruvate injection
  • Taoyuan City, Guishan District, Taiwan
    Chang Gung Memorial Hospital
Apr 5, 2023

Primary Aldosteronism Trial in Calgary ([18-F]CETO)

Not yet recruiting
  • Primary Aldosteronism
  • [18-F]CETO
  • Calgary, Alberta, Canada
    University of Calgary
Jul 22, 2022

Drug Abuse, Genotoxicity Trial in Tonala (Folic Acid 5 MG)

Not yet recruiting
  • Drug Abuse
  • Genotoxicity
  • Folic Acid 5 MG
  • Tonala, Jalisco, Mexico
    CUTONALA
Jan 25, 2023

Fibromyalgia Based on Cognitive Tasks

Recruiting
  • Fibromyalgia
  • Color Comparison Task
  • N-back Task
  • Oro Verde, Entre Ríos, Argentina
    Center for Nuclear and Molecular Medicine Entre Ríos (CEMENER)
Jun 15, 2023

Advanced Alveolar Soft Part Sarcoma, Advanced Soft Tissue Sarcoma, Metastatic Alveolar Soft Part Sarcoma Trial run by the NCI

Recruiting
  • Advanced Alveolar Soft Part Sarcoma
  • +3 more
  • Atezolizumab
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jan 28, 2023

Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • +3 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 21, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Philadelphia (Magnetic Resonance Imaging, Computed

Not yet recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Magnetic Resonance Imaging
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Thyroid Gland Carcinoma Trial in Houston (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging)

Recruiting
  • Thyroid Gland Carcinoma
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Intracranial Tumor Trial in Portland (Magnetic Resonance Imaging, Oxygen Therapy)

Recruiting
  • Intracranial Neoplasm
  • Magnetic Resonance Imaging
  • Oxygen Therapy
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 6, 2023

Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients Trial in Assiut (Radioactive Iodine therapy)

Recruiting
  • Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients
  • Radioactive Iodine therapy
  • Assiut, Egypt
    Nuclear medicine unit, department of clinical oncology and nucle
Dec 8, 2022

Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma Trial in Los Angeles (Biospecimen Collection, Magnetic Resonance

Recruiting
  • Glioblastoma
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Chemical Accident, Radiation Exposure, Biological Substance Poisoning Trial in Bursa (Mastery Learning Model for Chemical,

Completed
  • Chemical Accident
  • +2 more
  • Mastery Learning Model for Chemical, Biological, Radiological, and Nuclear threats and hazards (MLM-CBRN Education Program) on student nurses
  • Bursa, Nilüfer, Turkey
    Bursa Uludağ Üniversitesi
Jun 5, 2022

Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Biospecimen Collection
  • +8 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 9, 2023

Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

Recruiting
  • Neuroendocrine Tumors
  • Innsbruck, Austria
  • +2 more
May 12, 2023

Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)

Active, not recruiting
  • Recurrent Melanoma
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

Not yet recruiting
  • Myeloproliferative Neoplasms (MPNs)
  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
  • (no location specified)
Mar 24, 2023

Respiratory Disease-associated CHanges in Lung Physiology

Recruiting
  • Asthma
  • +3 more
    • Sheffield, South Yorkshire, United Kingdom
      Academic Unit of Radiology, Univeristy of Sheffield
    Jun 7, 2022

    Amyloidosis, Transthyretin Amyloid Cardiomyopathy Trial in Portland (99m-technetium pyrophosphate scintigraphy)

    Recruiting
    • Amyloidosis
    • Transthyretin Amyloid Cardiomyopathy
    • 99m-technetium pyrophosphate scintigraphy
    • Portland, Oregon
      Oregon Health & Science University
    Feb 17, 2022

    Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

    Not yet recruiting
    • Recurrent Glioblastoma, IDH-Wildtype
    • +2 more
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    May 13, 2023

    Assessing Exclusive Breastfeeding Practice

    Completed
    • Exclusive Breastfeeding
    • +2 more
    • Deuterium dose-to-mother method for assessing breastfeeding
    • (no location specified)
    Jul 23, 2023

    Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

    Completed
    • Neuroendocrine Tumor
    • Lutetium-177 DOTATATE
    • Houston, Texas
      Excel Diagnostics & Nuclear Oncology Center
    Apr 16, 2023